Key Players
Competitive Landscape
Strain evidence, viable-count stability and regulatory reach will decide the probiotic ingredient suppliers that gain contracts through 2036. Strain platforms will gain share through large libraries and fermentation scale. Solution providers rely on formulation support and clinical files. Proprietary strain specialists sell a few heavily studied strains at higher margins. Supplier positions will shift slowly because buyers seldom requalify an approved culture. For strain owners eyeing growth, heat-stable feed cultures and new country approvals will be the next strategic move. Novonesis launched Bovacillus in April 2026, and Kerry gained a live culture claim in Indonesia in February 2026. Analysts at FMI see suppliers with end-of-shelf-life data securing the next round of contracts.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| Kerry Group plc | February 2026: BPOM approved BC30 for a live culture claim in Indonesia | Food makers want live culture claims on ambient products. | Spore formers are moving into general food categories. | Country approvals can open new food and beverage accounts in Southeast Asia. |
| Novonesis | April 2026: Bovacillus Bacillus probiotic for dairy cows launched in Europe | Dairy farmers face rising feed costs. | Heat-stable probiotics are entering pelleted feed. | Feed efficiency claims can support premium feed additives. |
| International Flavors & Fragrances Inc. | April 2026: PureStrong canine probiotic launched in powder, capsule, tablet and stick formats | Pet owners seek digestive support for dogs. | Host-specific strains are replacing repurposed human strains. | One strain across several formats can widen pet supplement sales. |
| BioGaia AB | May 2026: Protectis Plus dual-strain drops launched in the UK | Parents seek relief for infant colic. | Brands pair established strains with new patented strains. | Strain combinations can extend patent life and pricing. |
| Novonesis | June 2026: agreement with UndoAge on stomach and women's health biotics in China | Chinese consumers seek science-backed wellness products. | Global strain owners are partnering with local brands. | Local partners can speed shelf access in China. |
Source: FMI, Probiotic Ingredients Market Report, 2026-2036.
Who Leads the Probiotic Ingredients Market?
No single supplier controls probiotic ingredient supply. Novonesis, Lallemand Inc., International Flavors & Fragrances Inc. and Archer Daniels Midland Company lead in strain libraries and bulk microbial manufacturing. DSM-Firmenich, Kerry Group plc and Probi AB lead in strains packaged with formulation and clinical support. BioGaia AB, Morinaga Milk Industry Co., Ltd. and Gnosis by Lesaffre lead in a few heavily studied proprietary strains.
Which Companies Run Large Strain Platforms?
Large strain platforms come mainly from Novonesis, Lallemand Inc., International Flavors & Fragrances Inc. and Archer Daniels Midland Company. Novonesis launched Bovacillus for dairy cows in April 2026. Lallemand runs the Saint-Simon plant in France, which makes more than 80 million sachets a year. ADM sells lactic acid bacteria and spore-forming strains in bulk and finished dosage forms.
Which Companies Provide Probiotic Application Solutions?
Demand for strain and formulation support is served by DSM-Firmenich, Kerry Group plc and Probi AB. Kerry gained a live culture claim for BC30 in Indonesia in February 2026. Probi, part of Symrise since 2025, reports more than 450 scientific publications across the company's strains. DSM-Firmenich sells probiotics under the Humiome brand alongside wider nutrition ingredients.
Which Companies Specialize in Proprietary Probiotic Strains?
Adoption of proprietary strains is led by BioGaia AB, Morinaga Milk Industry Co., Ltd. and Gnosis by Lesaffre. BioGaia launched Protectis Plus in the UK in May 2026 and sells in more than 100 markets. Morinaga refreshed the HRB bifidobacteria ingredient brand at Vitafoods Europe in May 2026. Gnosis by Lesaffre sells probiotic yeasts such as Lynside S. boulardii and ibSium.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Novonesis | Biosolutions group formed from Novozymes and Chr. Hansen, supplying probiotic strains for human health, food and animal feed. | In April 2026, Novonesis launched Bovacillus for dairy cows. In June 2026, the company signed an agreement with UndoAge on biotics for China. |
| DSM-Firmenich | Nutrition and health ingredient group selling Humiome probiotics alongside wider vitamin and nutrition lines. | DSM-Firmenich presented research on the Humiome Post LB postbiotic at IPA World Congress and Probiota 2026 in February 2026. |
| Lallemand Inc. | Canadian microbial group with strain production, contract manufacturing and ready-to-market probiotic formulas. | In February 2026, Lallemand Health Solutions reported EUR 20 million invested at Saint-Simon over 7 years and a new encapsulation line. |
| Kerry Group plc | Taste and nutrition company supplying the BC30 spore-forming probiotic to food, beverage and supplement makers. | In February 2026, BC30 gained a live culture claim approval from BPOM in Indonesia. |
| BioGaia AB | Swedish probiotics company built on proprietary L. reuteri strains for pediatric and adult health. | In May 2026, BioGaia launched Protectis Plus drops in the UK. |
| Probi AB | Swedish probiotic strain developer, part of Symrise since 2025, with LP299V as the lead strain. | In July 2026, Probi marked 35 years since the discovery of LP299V, with more than 300 publications on the strain. |
| International Flavors & Fragrances Inc. | Ingredient group selling HOWARU probiotics for human and pet health. | In April 2026, IFF launched PureStrong, a canine probiotic offered in powder, capsule, tablet and stick formats. |
| Archer Daniels Midland Company | Ingredient group with lactic acid bacteria and spore-forming probiotic strains such as DE111 and BPL1. | ADM offers probiotics in bulk and finished dosage forms for supplements, foods and beverages. |
| Morinaga Milk Industry Co., Ltd. | Japanese dairy and ingredient company selling HRB bifidobacteria strains to food and supplement makers. | In May 2026, Morinaga refreshed the HRB ingredient brand at Vitafoods Europe in Barcelona. |
| Gnosis by Lesaffre | Lesaffre business unit selling probiotic yeasts and bacteria for nutraceutical and pharmaceutical use. | In March 2026, Gnosis by Lesaffre presented the Quatreflora and ibSium probiotic yeasts at Natural Products Expo West. |
Company Selection and Benchmark Notes
Companies enter the benchmark when cited evidence links a company's probiotic strains, plants or ingredient sales to this market. Chr. Hansen Holding A/S, named in the draft data, now sits inside Novonesis after the 2024 merger with Novozymes, so the benchmark scores Novonesis. Danone S.A. and Yakult Honsha Co., Ltd. were replaced by Morinaga Milk Industry Co., Ltd. and Gnosis by Lesaffre, since the two consumer brands make finished probiotic products and do not sell strains as third-party ingredients. Probi AB is scored as a Symrise company. The FMI benchmark uses documented criteria and scores limited public documentation as Low. Stated applications connect each company development to demand drivers and product trends.
